Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Protective molecular mimicry in experimental myasthenia gravis.

Im SH, Barchan D, Feferman T, Raveh L, Souroujon MC, Fuchs S.

J Neuroimmunol. 2002 May;126(1-2):99-106.

PMID:
12020961
2.

Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.

Im SH, Barchan D, Maiti PK, Raveh L, Souroujon MC, Fuchs S.

FASEB J. 2001 Oct;15(12):2140-8.

PMID:
11641240
3.
4.
5.

Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.

Im SH, Barchan D, Souroujon MC, Fuchs S.

J Immunol. 2000 Oct 1;165(7):3599-605.

6.
7.
8.

Modulation of experimental autoimmune myasthenia gravis by recombinant fragments of the human acetylcholine receptor.

Souroujon MC, Barchan D, Fuchs S.

Ann N Y Acad Sci. 1998 May 13;841:572-5. No abstract available.

PMID:
9668298
9.

The mongoose neuronal acetylcholine receptor (alpha 7) binds alpha-bungarotoxin.

Ariel S, Asher O, Barchan D, Ovadia M, Fuchs S.

Ann N Y Acad Sci. 1998 May 13;841:93-6. No abstract available.

PMID:
9668224
10.
11.

Two subsites in the binding domain of the acetylcholine receptor: an aromatic subsite and a proline subsite.

Kachalsky SG, Jensen BS, Barchan D, Fuchs S.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10801-5.

12.

Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.

Barchan D, Balass M, Souroujon MC, Katchalski-Katzir E, Fuchs S.

J Immunol. 1995 Nov 1;155(9):4264-9.

PMID:
7594584
13.

The binding site of the nicotinic acetylcholine receptor in animal species resistant to alpha-bungarotoxin.

Barchan D, Ovadia M, Kochva E, Fuchs S.

Biochemistry. 1995 Jul 18;34(28):9172-6.

PMID:
7619817
14.

Molecular evolution of the binding site of the acetylcholine receptor.

Fuchs S, Barchan D, Kachalsky S, Neumann D, Aladjem M, Vogel Z, Ovadia M, Kochva E.

Ann N Y Acad Sci. 1993 Jun 21;681:126-39. No abstract available.

PMID:
8357160
15.

The ligand binding domain of the nicotinic acetylcholine receptor. Immunological analysis.

Kachalsky SG, Aladjem M, Barchan D, Fuchs S.

FEBS Lett. 1993 Mar 8;318(3):264-8.

16.

How the mongoose can fight the snake: the binding site of the mongoose acetylcholine receptor.

Barchan D, Kachalsky S, Neumann D, Vogel Z, Ovadia M, Kochva E, Fuchs S.

Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7717-21.

17.

Snake acetylcholine receptor: cloning of the domain containing the four extracellular cysteines of the alpha subunit.

Neumann D, Barchan D, Horowitz M, Kochva E, Fuchs S.

Proc Natl Acad Sci U S A. 1989 Sep;86(18):7255-9.

18.

Synthetic peptides and their antibodies in the analysis of the acetylcholine receptor.

Fuchs S, Neumann D, Safran A, Souroujon M, Barchan D, Fridkin M, Gershoni JM, Mantegazza R, Pizzighella S.

Ann N Y Acad Sci. 1987;505:256-71. No abstract available.

PMID:
2446550
19.

Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit.

Neumann D, Barchan D, Fridkin M, Fuchs S.

Proc Natl Acad Sci U S A. 1986 Dec;83(23):9250-3.

20.

Mapping of the alpha-bungarotoxin binding site within the alpha subunit of the acetylcholine receptor.

Neumann D, Barchan D, Safran A, Gershoni JM, Fuchs S.

Proc Natl Acad Sci U S A. 1986 May;83(9):3008-11.

21.

Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.

Souroujon MC, Barchan D, Fuchs S.

Immunol Lett. 1985;9(6):331-6.

PMID:
3874156

Supplemental Content

Loading ...
Support Center